Key result
A woman with lupus myocarditis treated with high-dose intravenous pulse methylprednisolone showed cardiac improvement but subsequently developed a fatal, unexplained sudden pneumomediastinum.
Case Report (n=1)
This case highlights a rare and fatal occurrence of sudden unexplained pneumomediastinum in a patient being treated for lupus myocarditis with high-dose corticosteroids.
Answers are grounded in this paper and cite their sources.
Warrants vigilance for pneumomediastinum during pulse steroids in lupus myocarditis; leaves open causality and requires confirmation.
Systemic lupus erythematous (SLE) is systemic autoimmune disease of unknown etiology. SLE involve all part of heart but clinically important myocarditis is an unusual feature and is potentially fatal complication of SLE. We describe the woman who had diagnosed as SLE, 5 years ago and in that time, she had sinus tachycardia, mild dyspnea, chest discomfort, and depressed left ventricular function. She was diagnosed to myocarditis clinically and was treated by high-dose corticosteroids of intravenous pulse methylprednisolone. After treatment, she improved and showed improvement of left ventricular function. However, a sudden pneumomediastinum was occurred without trauma, and she died. The cause of pneumomediastinum was unexplained. We report a sudden pneumomediastinum in the course of lupus myocarditis presenting as sinus tachycardia with review of literature.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2008) conducted a case report in Lupus Myocarditis (n=1). High-dose corticosteroids (intravenous pulse methylprednisolone) was evaluated on Clinical course and development of pneumomediastinum. A woman with lupus myocarditis treated with high-dose intravenous pulse methylprednisolone showed cardiac improvement but subsequently developed a fatal, unexplained sudden pneumomediastinum.
Synapse has enriched 10 related papers. Consider them for comparative context: